Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

15.60
Delayed Data
As of May 26
 -0.55 / -3.41%
Today’s Change
7.02
Today|||52-Week Range
18.50
+28.93%
Year-to-Date

Today’s Trading

Previous close16.15
Today’s open16.10
Day’s range15.45 - 16.43
Volume362,803
Average volume (3 months)425,199
Market cap$910.4M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+41.87%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+212.77%
P/E ratioNM
Price/Sales86.33
Price/Book4.49

Competitors

 Today’s
change
Today’s
% change
XLRNAcceleron Pharma Inc-1.20-4.54%
FPRXFive Prime Therapeut...-0.84-2.82%
MYOVMyovant Sciences Ltd+0.30+2.31%
CHRSCoherus BioSciences ...+0.05+0.25%
Data as of 4:00pm ET, 05/26/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$8.0M
Annual profit (last year)-$110.2M
Net profit margin-1,376.45%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert B. Bazemore
Chief Operating Officer
Matthew E. Ros
Corporate headquarters
Cambridge, Massachusetts

Forecasts